Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

被引：0
|
作者：
N C Tebbutt
M M Cummins
T Sourjina
A Strickland
G Van Hazel
V Ganju
D Gibbs
M Stockler
V Gebski
J Zalcberg
机构：
[1] Austin Health,Department of Medical Oncology
[2] PO Box 5555,undefined
[3] Studley Road,undefined
[4] Heidelberg,undefined
[5] Melbourne,undefined
[6] Victoria 3084,undefined
[7] Australia,undefined
[8] National Health and Medical Research Council Clinical Trials Centre,undefined
[9] University of Sydney,undefined
[10] Locked Bag 77,undefined
[11] Camperdown,undefined
[12] Sydney,undefined
[13] New South Wales 1450,undefined
[14] Australia,undefined
[15] Monash Medical Centre,undefined
[16] 246 Clayton Road,undefined
[17] Clayton,undefined
[18] Melbourne,undefined
[19] Victoria 3168,undefined
[20] Australia,undefined
[21] Sir Charles Gairdner Hospital,undefined
[22] Hospital Avenue,undefined
[23] Nedlands,undefined
[24] Perth,undefined
[25] Western Australia 6009,undefined
[26] Australia,undefined
[27] Frankston Hospital,undefined
[28] PO Box 52,undefined
[29] Frankston,undefined
[30] Melbourne,undefined
[31] Victoria 3199,undefined
[32] Australia,undefined
[33] Christchurch Hospital,undefined
[34] 2 Riccarton Avenue,undefined
[35] Addington,undefined
[36] Christchurch,undefined
[37] Canterbury 8011,undefined
[38] New Zealand,undefined
[39] Peter MacCallum Cancer Centre,undefined
[40] St Andrews Place,undefined
[41] East Melbourne,undefined
[42] Melbourne,undefined
[43] Victoria 3002,undefined
[44] Australia,undefined
来源：
British Journal of Cancer | 2010年 / 102卷
关键词：
advanced gastric cancer; advanced oesophageal cancer; cisplatin; 5-fluorouracil; capecitabine; docetaxel;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：475 / 481
页数：6
相关论文
共 50 条
  • [1] Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
    Tebbutt, N. C.
    Cummins, M. M.
    Sourjina, T.
    Strickland, A.
    Van Hazel, G.
    Ganju, V.
    Gibbs, D.
    Stockler, M.
    Gebski, V.
    Zalcberg, J.
    BRITISH JOURNAL OF CANCER, 2010, 102 (03) : 475 - 481
  • [2] Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial
    Tebbutt, Niall C.
    Price, Timothy J.
    Ferraro, Danielle A.
    Wong, Nicole
    Veillard, Anne-Sophie
    Hall, Merryn
    Sjoquist, Katrin M.
    Pavlakis, Nick
    Strickland, Andrew
    Varma, Suresh C.
    Cooray, Prasad
    Young, Rosemary
    Underhill, Craig
    Shannon, Jennifer A.
    Ganju, Vinod
    Gebski, Val
    BRITISH JOURNAL OF CANCER, 2016, 114 (05) : 505 - 509
  • [3] A phase II pilot study of weekly docetaxel cisplatin and 5-fluorouracil in metastatic gastric cancer.
    Okutur, K.
    Dane, F.
    Ilhan, M.
    Seber, S.
    Korkmaz, T.
    Aydin, K.
    Bozkurt, M.
    Namal, E.
    Turhal, N. S.
    Demir, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial
    Niall C Tebbutt
    Timothy J Price
    Danielle A Ferraro
    Nicole Wong
    Anne-Sophie Veillard
    Merryn Hall
    Katrin M Sjoquist
    Nick Pavlakis
    Andrew Strickland
    Suresh C Varma
    Prasad Cooray
    Rosemary Young
    Craig Underhill
    Jennifer A Shannon
    Vinod Ganju
    Val Gebski
    British Journal of Cancer, 2016, 114 : 505 - 509
  • [5] ATTAX: Randomised phase II study evaluating weekly docetaxel-based chemotherapy combinations in advanced esophago- gastric cancer, final results of an AGITG trial
    Tebbutt, N.
    Sourjina, T.
    Strickland, A.
    Van Hazel, G.
    Ganju, V.
    Gibbs, D.
    Gebski, V.
    Munro, S.
    Cummins, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Phase II Study of Docetaxel and Cisplatin Chemotherapy in 5-Fluorouracil/Cisplatin Pretreated Esophageal Cancer
    Shim, Hyun-Jeong
    Cho, Sang-Hee
    Hwang, Jun-Eul
    Bae, Woo-Kyun
    Song, Sang-Yun
    Cho, Sung-Bum
    Lee, Wan-Sik
    Joo, Young-Eun
    Na, Kook-Joo
    Chung, Ik-Joo
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 624 - 628
  • [7] Phase II study of weekly paclitaxel, cisplatin, and 5-fluorouracil for advanced gastric cancer
    Hara, Takuo
    Nishikawa, Kazuhiro
    Sakatoku, Mitsuaki
    Oba, Koji
    Sakamoto, Junichi
    Omura, Kenji
    GASTRIC CANCER, 2011, 14 (04) : 332 - 338
  • [8] Phase II Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Unresectable Esophageal Cancer
    Takahashi, Kosuke
    Osaka, Yoshiaki
    Ota, Yoshihiro
    Watanabe, Takafumi
    Iwasaki, Kenichi
    Tachibana, Shingo
    Nagakawa, Yuichi
    Katsumata, Kenji
    Tsuchida, Akihiko
    ANTICANCER RESEARCH, 2020, 40 (05) : 2827 - 2832
  • [9] Phase II study of weekly paclitaxel, cisplatin, and 5-fluorouracil for advanced gastric cancer
    Takuo Hara
    Kazuhiro Nishikawa
    Mitsuaki Sakatoku
    Koji Oba
    Junichi Sakamoto
    Kenji Omura
    Gastric Cancer, 2011, 14 : 332 - 338
  • [10] PHASE II STUDY OF WEEKLY PACLITAXEL, CISPLATIN, AND 5-FLUOROURACIL (PCF) FOR ADVANCED GASTRIC CANCER
    Nishikawa, K.
    Hara, T.
    Sakatoku, M.
    Oba, K.
    Abe, C.
    Sakamoto, J.
    Omura, K.
    ANNALS OF ONCOLOGY, 2010, 21 : 228 - 228
12345